Skip to content

Clinical trials

Completed Phase 2 Cholangiocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Status: Completed Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20041
20061
20071
20083
20093
20104
20114
20121
20134
20145
20155
20165
20177
201812
20196
20205
20217
20226
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Peking Union Medical College Hospital4
Memorial Sloan Kettering Cancer Center3
AIO-Studien-gGmbH2
M.D. Anderson Cancer Center2
Massachusetts General Hospital2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Vejle Hospital2
Washington University School of Medicine2
ASLAN Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma87
Gallbladder Neoplasms21
Biliary Tract Neoplasms19
Bile Duct Neoplasms10
Carcinoma, Hepatocellular8
Pancreatic Neoplasms7
Neoplasms6
Colorectal Neoplasms5
Klatskin Tumor4
Liver Neoplasms4

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.